Lite Strategy, Inc. (LITS)
1.10
+0.04
(+3.77%)
USD |
NASDAQ |
Sep 11, 16:00
1.10
0.00 (0.00%)
After-Hours: 17:07
Lite Strategy Gross Profit (TTM) : 0.00 for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | -0.368M |
| March 31, 2025 | -0.493M |
| December 31, 2024 | -0.579M |
| September 30, 2024 | -0.664M |
| June 30, 2024 | 64.54M |
| March 31, 2024 | 65.66M |
| December 31, 2023 | 71.18M |
| September 30, 2023 | 103.56M |
| June 30, 2023 | 47.00M |
| March 31, 2023 | 57.06M |
| December 31, 2022 | 61.04M |
| September 30, 2022 | 40.51M |
| June 30, 2022 | 39.91M |
| March 31, 2022 | 36.24M |
| December 31, 2021 | 34.52M |
| September 30, 2021 | 34.87M |
| June 30, 2021 | 30.51M |
| March 31, 2021 | 48.15M |
| December 31, 2020 | 40.83M |
| September 30, 2020 | 29.10M |
| June 30, 2020 | 26.24M |
| March 31, 2020 | 1.248M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.95M |
| September 30, 2019 | 1.622M |
| June 30, 2019 | 0.652M |
| March 31, 2019 | 0.065M |
| December 31, 2018 | -0.518M |
| September 30, 2018 | -1.927M |
| June 30, 2018 | -1.761M |
| March 31, 2018 | -1.741M |
| December 31, 2017 | 2.114M |
| September 30, 2017 | 17.91M |
| June 30, 2017 | 18.25M |
| March 31, 2017 | 18.78M |
| December 31, 2016 | 15.40M |
| September 30, 2016 | -0.041M |
| June 30, 2016 | -0.058M |
| March 31, 2016 | -0.061M |
| December 31, 2015 | -0.063M |
| September 30, 2015 | -0.063M |
| June 30, 2015 | -0.064M |
| March 31, 2015 | -0.064M |
| December 31, 2014 | -0.057M |
| September 30, 2014 | -0.053M |
| June 30, 2014 | -0.05M |
| March 31, 2014 | -0.046M |
| December 31, 2013 | -0.05M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |